Related Experiment Video
Updated: Mar 31, 2026
Isolation of Endothelial Progenitor Cells from Human Umbilical Cord Blood
Published on: September 14, 2017
Are Endothelial Progenitor Cells the Real Solution for Cardiovascular Diseases? Focus on Controversies and
Carmela R Balistreri1, Silvio Buffa1, Calogera Pisano2
1Department of Pathobiology and Medical Biotechnologies, University of Palermo, 90134 Palermo, Italy.
Insights
Regenerative medicine offers potential for cardiovascular diseases (CVDs), but research on endothelial progenitor cells (EPCs) lacks consistent evidence. Clarifying EPC characterization is crucial for their clinical application as biomarkers and therapeutics.
Area of Science:
- Regenerative Medicine
- Stem Cell Biology
- Cardiovascular Diseases (CVDs)
Background:
- Regenerative medicine is a promising field for treating cardiovascular diseases (CVDs).
- Research on endothelial progenitor cells (EPCs) for CVDs faces challenges due to inconsistent evidence and confusion.
- The clinical application of regenerative medicine for CVDs is hampered by a lack of consistent data.
Purpose of the Study:
- To review the biology and physiology of endothelial progenitor cells (EPCs).
- To outline the clinical relevance of EPCs as predictive, diagnostic, and prognostic biomarkers for CVDs.
- To discuss the therapeutic potential of EPCs for vascular impairment and clinical applications.
Main Methods:
- Literature review focusing on endothelial progenitor cells (EPCs) in cardiovascular diseases.
- Analysis of existing data regarding EPCs' role as biomarkers and therapeutic agents.
- Discussion of conflicting data and challenges in EPC characterization and definition.
Main Results:
- EPCs hold potential as both biomarkers and therapeutic agents for cardiovascular diseases (CVDs).
- Significant heterogeneity exists in literature data concerning EPCs, largely due to issues with characterization and definition.
- The advantages, disadvantages, and conflicting data regarding EPCs' clinical use require careful consideration.
Conclusions:
- Standardized characterization and definition of EPCs are essential to resolve inconsistencies in research data.
- Addressing these issues will facilitate the clinical translation of EPC-based regenerative medicine for cardiovascular diseases.
- Clarifying EPC biology and application is critical for advancing regenerative therapies for CVDs.
Abstract:
Advanced knowledge in the field of stem cell biology and their ability to provide a cue for counteracting several diseases are leading numerous researchers to focus their attention on "regenerative medicine" as possible solutions for cardiovascular diseases (CVDs). However, the lack of consistent evidence in this arena has hampered the clinical application. The same condition affects the research on endothelial progenitor cells (EPCs), creating more confusion than comprehension. In this review, this aspect is discussed with particular emphasis. In particular, we describe biology and physiology of EPCs, outline their clinical relevance as both new predictive, diagnostic, and prognostic CVD biomarkers and therapeutic agents, discuss advantages, disadvantages, and conflicting data about their use as possible solutions for vascular impairment and clinical applications, and finally underline a very crucial aspect of EPCs "characterization and definition," which seems to be the real cause of large heterogeneity existing in literature data on this topic.
More Related Videos
08:43Isolation of Endothelial Progenitor Cells from Healthy Volunteers and Their Migratory Potential Influenced by Serum Samples After Cardiac Surgery
Published on: February 14, 2017
13:46Phenotypic and Functional Characterization of Endothelial Colony Forming Cells Derived from Human Umbilical Cord Blood
Published on: April 13, 2012
Related Concept Videos
00:57Embryonic Stem Cells
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
01:24Regulation of Angiogenesis and Blood Supply